한국어
English
日本語
中文(简体)
Xtandi Soft Capsule 40mg (Enzalutamide)
40mg
Soft capsule · Prescription medication
Astellas Pharma Korea, Co., Ltd.
Enzalutamide is an anti-androgen component used in the treatment of prostate cancer.
MFDS ingredient code M257255
Enzalutamide is classified as an anti-cancer agent within the anti-androgen drug category. It is primarily used for the treatment of prostate cancer and functions by blocking the androgen receptors necessary for the growth of cancer cells. This action suppresses the proliferation of cancer cells.
Enzalutamide binds to androgen receptors in the body and prevents male hormones from attaching to these receptors. As a result, the signaling required for the growth of prostate cancer cells is blocked, inhibiting the proliferation of cancer cells.
Approved uses differ by product. Check each product's information for its actual use.
Enzalutamide has a stronger binding affinity to receptors compared to existing anti-androgen drugs and also inhibits the translocation of receptors to the nucleus. This characteristic is believed to enhance the efficacy of prostate cancer treatment.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
3 total
40mg
Soft capsule · Prescription medication
Astellas Pharma Korea, Co., Ltd.
80mg
Tablet · Prescription medication
Hanmi Astellas Pharma Co., Ltd.
40mg
Tablet · Prescription medication
Korea Astellas Pharma Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.